Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.

By M. Shibuya, L. Claesson‐Welsh. Experimental Cell Research, 2006

1,081 citations recorded by the source corpus.

Subfields: Immunology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/dc263339d1f5830cbffba968255e6b4aa4017d6d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. M. Shibuya
2. Peter Libby

In Molecular Biology

1. Huanhuan Chen
2. Li-li Zheng
3. Zhenling Liu
4. Li-Ping Sun
5. Lei Shi
6. M. Shibuya
7. J. Pober
8. W. Sessa

In Oncology

1. M. Shibuya
2. J. Pober
3. W. Sessa

Citations in the corpus

• Role of Matrix Metalloproteinases in Angiogenesis and Cancer (2019, background): “The activation of ECs also triggers a branching process toward the central region of the tumor (49, 50).”
• Angiogenic signaling pathways and anti-angiogenic therapy for cancer (2023, background): “VEGF regulates vascular permeability, angiogenesis, and lymphogenesis.(83) VEGF family consists of seven members, including VEGF-A, VEGF-B, VEGF-C, VEGF-D, placental growth factor (PlGF), and nonhuman genome encoded VEGF-E and svVEGF.”
• Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth (2015, background): “The VEGF receptor was also discovered soon [69].”
• Vascular endothelial growth factor (VEGF) signaling in tumor progression. (2007, neutral): “[129] Shibuya M, Claesson-Welsh L.”
• Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies. (2011, background): “VEGF-A binds to and activates both VEGFR-1 and VEGFR-2, promoting angiogenesis, vascular permeability, cell migration, and gene expression.(5) In addition, Lee et al.”
• Evolving functions of endothelial cells in inflammation (2007, background): “Three signalling pathways are typically activated in endothelial cells for effective angiogenesis: the RAS–extracellular-signal-regulated kinase 1 (ERK1)/ERK2 pathway, the phosphoinositide 3-kinase (PI3K)–AKT pathway and the Ca 2+ –PLCγ pathwa”
• Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. (2013, background): “x-M motif, and the PI3K pathway is usually not highly activated after stimulation with VEGF (3).”